Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cellular phospholipid bilayer is a fundamental biological structure composed of two layers of amphipathic lipid molecules that form a continuous, semi-permeable barrier around cells and organelles (StatPearls, 2023, https://www.ncbi.nlm.nih.gov/books/NBK554421/). It serves as a critical matrix for membrane proteins and plays a vital role in maintaining ion gradients, regulating molecular transport, and facilitating signal transduction (NIH, 2022). In therapeutic contexts, the bilayer is a primary target for several classes of antimicrobial agents, such as polymyxins and lipopeptides, which disrupt membrane integrity to induce rapid cell death in pathogens (PubMed, 2014, https://pubmed.ncbi.nlm.nih.gov/25130014/). For instance, daptomycin inserts into the bacterial membrane in a calcium-dependent manner, causing depolarization and loss of membrane potential (PubMed, 2004, https://pubmed.ncbi.nlm.nih.gov/14744908/). Similarly, antifungal agents like amphotericin B bind to ergosterol within the fungal lipid bilayer to create lethal transmembrane pores (PubChem, 2024, https://pubchem.ncbi.nlm.nih.gov/compound/Amphotericin-B). While highly effective, targeting the phospholipid bilayer requires high specificity to avoid damaging host cell membranes, which can result in significant side effects like hemolysis or organ toxicity. Understanding the lipid composition and biophysical properties of the bilayer is essential for developing drugs that can selectively penetrate or disrupt specific membranes in disease states.
Drugs targeting the phospholipid bilayer typically act through physical disruption of the membrane structure, including pore formation, membrane depolarization, and alteration of lipid packing, which leads to the leakage of essential intracellular contents and rapid cell death.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular phospholipid bilayer.